Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy

Retrieved on: 2025-09-24 18:51:42

Tags for this article:

Click the tags to see associated articles and topics

Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy. View article details on hiswai:

Excerpt

... US Venture Partners. In conjunction with the financing, Zach Scheiner from RA and Nanna Lüneborg from Forbion have joined Sparrow's Board of ...

Article found on: www.bakersfield.com